approved

Приложение 4 на ПЛС от 02.03.2020 г.

Unique identificator:  cf27a960-59b5-4430-be4a-5bac8000c338

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2020-03-04 09:33:47
  • Created by: georgi_sivchev
  • Updated at: 2020-03-04 09:33:47
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/004 Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 1408.2 281.64 1689.84 4% 10 1418.2 283.64 1701.84 16% 25 1443.2 288.64 1731.84 НСР-12362/18.04.2017 03.05.2017 02.06.2017 Неактивен 15668
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/002 Elocta, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial (powder)+ 1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 612.39 122.48 734.87 4% 10 622.39 124.48 746.87 16% 25 647.39 129.48 776.87 НСР-18707/20.05.2019 и КП-86/14.11.2019 НСР-12362/18.04.2017; НСР-13653/01.09.2017; КП-55/19.06.2019 и НСР-17248/14.11.2018 02.08.2019 02.01.2020 Активен 15667
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/002 Elocta, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial (powder)+ 1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 612.39 122.48 734.87 4% 10 622.39 124.48 746.87 16% 25 647.39 129.48 776.87 НСР-12362/18.04.2017; НСР-13653/01.09.2017; КП-55/19.06.2019 и НСР-17248/14.11.2018 02.08.2019 02.08.2019 Неактивен 15667
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/002 Elocta, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial (powder)+ 1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 612.39 122.48 734.87 4% 10 622.39 124.48 746.87 16% 25 647.39 129.48 776.87 НСР-12362/18.04.2017; НСР-13653/01.09.2017; КП-55/19.06.2019 и НСР-17248/14.11.2018 02.08.2019 02.08.2019 Неактивен 15667
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/002 Elocta, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial (powder)+ 1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 633.69 126.74 760.43 4% 10 643.69 128.74 772.43 16% 25 668.69 133.74 802.43 НСР-12362/18.04.2017; НСР-13653/01.09.2017 16.09.2017 02.10.2017 Неактивен 15667
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/002 Elocta, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial (powder)+ 1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 704.1 140.82 844.92 4% 10 714.1 142.82 856.92 16% 25 739.1 147.82 886.92 НСР-12362/18.04.2017 02.06.2017 02.06.2017 Неактивен 15667
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/005 Elocta, Powder and solvent for solution for injection, 1500, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 1837.17 367.43 2204.6 4% 10 1847.17 369.43 2216.6 16% 25 1872.17 374.43 2246.6 НСР-18711/20.05.2019 и КП-86/14.11.2019 НСР-15271/16.03.2018 Предварително изпълнение; КП-53/19.06.2019 и НСР-17246/14.11.2018 02.08.2019 02.01.2020 Активен 16049
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/005 Elocta, Powder and solvent for solution for injection, 1500, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 1837.17 367.43 2204.6 4% 10 1847.17 369.43 2216.6 16% 25 1872.17 374.43 2246.6 НСР-15271/16.03.2018 Предварително изпълнение; КП-53/19.06.2019 и НСР-17246/14.11.2018 02.08.2019 02.08.2019 Неактивен 16049
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/006 Elocta, Powder and solvent for solution for injection, 2000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 2449.56 489.91 2939.47 4% 10 2459.56 491.91 2951.47 16% 25 2484.56 496.91 2981.47 НСР-18713/20.05.2019 и КП-86/14.11.2019 НСР-15271/16.03.2018 Предварително изпълнение; КП-52/19.06.2019 и НСР-17245/14.11.2018 02.08.2019 02.01.2020 Активен 16050
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/006 Elocta, Powder and solvent for solution for injection, 2000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 2449.56 489.91 2939.47 4% 10 2459.56 491.91 2951.47 16% 25 2484.56 496.91 2981.47 НСР-15271/16.03.2018 Предварително изпълнение; КП-52/19.06.2019 и НСР-17245/14.11.2018 02.08.2019 02.08.2019 Неактивен 16050
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/007 Elocta, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 3674.36 734.87 4409.23 4% 10 3684.36 736.87 4421.23 16% 25 3709.36 741.87 4451.23 НСР-18714/20.05.2019 и КП-86/14.11.2019 НСР-15271/16.03.2018 Предварително изпълнение; КП-51/19.06.2019 и НСР-17244/14.11.2018 02.08.2019 02.01.2020 Активен 16051
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/007 Elocta, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 3674.36 734.87 4409.23 4% 10 3684.36 736.87 4421.23 16% 25 3709.36 741.87 4451.23 НСР-15271/16.03.2018 Предварително изпълнение; КП-51/19.06.2019 и НСР-17244/14.11.2018 02.08.2019 02.08.2019 Неактивен 16051
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/007 Elocta, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 3674.36 734.87 4409.23 4% 10 3684.36 736.87 4421.23 16% 25 3709.36 741.87 4451.23 НСР-15271/16.03.2018 Предварително изпълнение; КП-51/19.06.2019 и НСР-17244/14.11.2018 02.08.2019 02.08.2019 Неактивен 16051
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/006 Elocta, Powder and solvent for solution for injection, 2000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 2449.56 489.91 2939.47 4% 10 2459.56 491.91 2951.47 16% 25 2484.56 496.91 2981.47 НСР-15271/16.03.2018 Предварително изпълнение; КП-52/19.06.2019 и НСР-17245/14.11.2018 02.08.2019 02.08.2019 Неактивен 16050
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/005 Elocta, Powder and solvent for solution for injection, 1500, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 1837.17 367.43 2204.6 4% 10 1847.17 369.43 2216.6 16% 25 1872.17 374.43 2246.6 НСР-15271/16.03.2018 Предварително изпълнение; КП-53/19.06.2019 и НСР-17246/14.11.2018 02.08.2019 02.08.2019 Неактивен 16049
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/005 Elocta, Powder and solvent for solution for injection, 1500, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 1901.07 380.21 2281.28 4% 10 1911.07 382.21 2293.28 16% 25 1936.07 387.21 2323.28 НСР-15271/16.03.2018 Предварително изпълнение 16.03.2018 02.04.2018 Неактивен 16049
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/007 Elocta, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 3802.13 760.43 4562.56 4% 10 3812.13 762.43 4574.56 16% 25 3837.13 767.43 4604.56 НСР-15271/16.03.2018 Предварително изпълнение 16.03.2018 02.04.2018 Неактивен 16051
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/006 Elocta, Powder and solvent for solution for injection, 2000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 2534.76 506.95 3041.71 4% 10 2544.76 508.95 3053.71 16% 25 2569.76 513.95 3083.71 НСР-15271/16.03.2018 Предварително изпълнение 16.03.2018 02.04.2018 Неактивен 16050
Corifollitropin alfa EU/1/09/609/001 Elonva, Solution for injection, 100 µg/0.5 ml, -, Pack: 1 pre-filled syringe + 1 needle Merck Sharp & Dohme B.V., Нидерландия N.V. Organon Kloosterstraat 6 5349 AB Oss The Netherlands; Organon (Ireland) Ltd. Drynam Road, Swords, Co. Dublin, Ireland 729.82 145.96 875.78 4% 10 739.82 147.96 887.78 16% 25 764.82 152.96 917.78 Промяна на обстоятелствата НСР-16938/04.10.2018 НСР-7655/01.12.2015.; НСР-20802/13.02.2020 28.02.2020 02.03.2020 Активен 3731
Corifollitropin alfa EU/1/09/609/001 Elonva, Solution for injection, 100 µg/0.5ml, -, Pack: 1 pre-filled syringe + 1 needle Merck Sharp & Dohme B.V., Нидерландия N.V. Organon Kloosterstraat 6 5349 AB Oss The Netherlands; Organon (Ireland) Ltd. Drynam Road, Swords, Co. Dublin Ireland 750.26 150.05 900.31 4% 10 760.26 152.05 912.31 16% 25 785.26 157.05 942.31 Промяна на обстоятелствата НСР-16938/04.10.2018 НСР-7655/01.12.2015. 16.12.2015 02.11.2018 Неактивен 3731
Corifollitropin alfa EU/1/09/609/001 Elonva, Solution for injection, 100 µg/0.5ml, -, Pack: 1 pre-filled syringe + 1 needle Merck Sharp & Dohme Ltd., Обединено Кралство N.V. Organon Kloosterstraat 6 5349 AB Oss The Netherlands; Organon (Ireland) Ltd. Drynam Road, Swords, Co. Dublin Ireland 750.26 150.05 900.31 4% 10 760.26 152.05 912.31 16% 25 785.26 157.05 942.31 НСР-7655/01.12.2015. 16.12.2015 16.12.2015 Неактивен 3731
Corifollitropin alfa EU/1/09/609/001 Elonva, Solution for injection, 0.1, mg/ 0.5ml, Pack: 1 Merck Sharp & Dohme Ltd., Обединено Кралство N.V. Organon Kloosterstraat 6 5349 AB Oss The Netherlands; Organon (Ireland) Ltd. Drynam Road, Swords, Co. Dublin Ireland 753.68 150.74 904.42 4% 10 763.68 152.74 916.42 16% 25 788.68 157.74 946.42 НСР-5956/01.04.2015. 16.04.2015 16.04.2015 Неактивен 3731
Corifollitropin alfa EU/1/09/609/001 Elonva, Solution for injection, 0.1, mg/ 0.5ml, Pack: 1 Merck Sharp & Dohme Ltd., Обединено Кралство N.V. Organon Kloosterstraat 6 5349 AB Oss The Netherlands; Organon (Ireland) Ltd. Drynam Road, Swords, Co. Dublin Ireland 769.87 153.97 923.84 4% 10 779.87 155.97 935.84 16% 25 804.87 160.97 965.84 корекц.НСР-4088/03.07.2014; промяна на обстоятелства НСР-4420/07.08.2014( в сила от 25.08.2014) НСР-3733/06.06.2014 04.07.2014 04.07.2014 Неактивен 3731
Corifollitropin alfa EU/1/09/609/001 Elonva, Solution for injection, 0.1, mg/ 0.5ml, Pack: 1 N.V. Organon, Нидерландия N.V. Organon Kloosterstraat 6 5349 AB Oss The Netherlands; Organon (Ireland) Ltd. Drynam Road, Swords, Co. Dublin Ireland 777.54 155.51 933.05 4% 10 787.54 157.51 945.05 16% 25 812.54 162.51 975.05 КЦРР-2589/14.03.2013 02.04.2013 02.04.2013 Неактивен 3731
Corifollitropin alfa EU/1/09/609/002/ 25.01.2010 Elonva, Solution for injection, 0.15, mg/ 0.5ml, Pack: 1 Merck Sharp & Dohme Ltd., Обединено Кралство N.V. Organon Netherlands Organon (Ireland) Ltd. Ireland 970.62 194.12 1164.74 4% 10 980.62 196.12 1176.74 16% 25 1005.62 201.12 1206.74 промяна на обстоятелства НСР-4419/07.08.2014 ( в сила от 25.08.2014) КЦРР-2059/24.01.2013 г 25.02.2013 25.02.2013 Неактивен 3715
Showing 4526 to 4551 of 17151 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте